The functions of MRPL33 and C2orf16 as solute carriers are not entirely known, but they have been reported to involve neuroendocrine diseases, such as autism spectrum disorder and type 2 diabetes [41,42]. This evidence concerns the gene SPATA31H1 and type 2 diabetes mellitus.